Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 3976 - 4000 of 4097 in total
Dapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus).
Investigational
Olinvacimab is under investigation in clinical trial NCT03033524 (Trial to Evaluate the Safety of Ttac-0001(tanibirumab) in Recurrent Glioblastoma).
Investigational
Investigational
CAN-106 a novel, long-acting monoclonal antibody directed against human complement C5.
Investigational
Displaying drugs 3976 - 4000 of 4097 in total